COMP <GO>
FTRE vs ABBV // FORWARD P/E MULTIPLE
Fortrea Holdings Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: FTRE 2
— ABBV 12
▲ FORWARD P/E MULTIPLE LEADER: FTRE
LAST: $21.29 (-7.99%) • MKT CAP: $2.20B
forward-pe
29.0x
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
forward-pe
113.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FTRE VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FTRE | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 70.20% | -29.20 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 29.00% | -64.00 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 33.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.41% | 3.47% | -3.88 | ABBV | /fcf-yield <GO> |
| Operating Margin | -32.00% | 24.60% | -56.60 | ABBV | /operating-margins <GO> |
| Net Profit Margin | -36.30% | 6.90% | -43.20 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 1.00% | 8.60% | -7.60 | ABBV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 5.33 | -4.88 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 7.40% | -0.50 | FTRE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.4 | 72.8 | -26.39 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 1.15 | -0.16 | ABBV | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 29.0x | 113.1x | -84.10 | FTRE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.20B | $513.86B | -$511.66B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FTRE REV | ABBV REV | FTRE GROSS % | ABBV GROSS % | FTRE FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.72B | $61.16B | 44.0% | 70.2% | -$9.1M | $17.82B |
| FY 2024 | $2.70B | $56.33B | 44.0% | 70.0% | $141.5M | $17.83B |
| FY 2023 | $2.84B | $54.32B | 44.0% | 44.0% | $40.5M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FTRE // BETA 0.99
ABBV // BETA 1.15